```html

Menstrual Bleeding Abnormalities

What is Menstrual Bleeding Abnormalities?

Menstrual bleeding abnormalities refer to any change in the pattern, amount, or duration of menstrual flow that falls outside what is considered a “normal” menstrual cycle. Normal cycles typically last 21‑35 days, last 2‑7 days, and involve a total blood loss of 30‑80 mL (about 2‑3 tampons or pads). When flow is significantly lighter, heavier, shorter, longer, or irregularly spaced, it is called menorrhagia (heavy bleeding), metrorrhagia (irregular bleeding), hypomenorrhea (light bleeding), or amenorrhea (absence of periods). These changes can be a sign of an underlying medical condition, a reaction to medication, or a natural hormonal shift.

Understanding why menstrual patterns shift is essential because chronic abnormalities can lead to anemia, impact quality of life, and, in some cases, signal serious disease such as cancer.

Common Causes

Below are the most frequently encountered conditions that can disrupt normal menstrual bleeding. Many of them overlap, and more than one cause may be present at the same time.

• Hormonal Imbalance – Fluctuations in estrogen and progesterone, often from polycystic ovary syndrome (PCOS) or perimenopause.
• Uterine Fibroids (Leiomyomas) – Benign muscle tumors that can enlarge the uterus and cause heavy or prolonged bleeding.
• Endometrial Polyps – Small growths on the uterine lining that frequently cause spotting or heavy flow.
• Adenomyosis – Endometrial tissue grows into the uterine muscle, leading to painful, heavy periods.
• Coagulation Disorders – Conditions such as von Willebrand disease or platelet function defects increase bleeding risk.
• Thyroid Dysfunction – Both hypothyroidism and hyperthyroidism can alter menstrual regularity.
• Intrauterine Contraceptive Devices (IUDs) – Hormonal IUDs may cause spotting, while copper IUDs can increase flow.
• Pregnancy‑Related Issues – Early pregnancy loss, ectopic pregnancy, or implantation bleeding can mimic abnormal periods.
• Medications & Substances – Anticoagulants, non‑steroidal anti‑inflammatory drugs (NSAIDs), and herbal supplements (e.g., ginkgo, ginger) can affect clotting.
• Cancer – Endometrial, cervical, or ovarian cancer can present with post‑menopausal bleeding or atypical spotting.

Associated Symptoms

Abnormal bleeding rarely occurs in isolation. Look for these accompanying signs, which can help pinpoint the underlying cause:

• Pelvic or lower‑back pain, especially during menses (often seen with fibroids, adenomyosis).
• Spotting between periods or after intercourse.
• Sudden weight gain or loss, facial hair growth, or acne (suggesting PCOS or hormonal shifts).
• Fatigue, shortness of breath, or pale skin – possible signs of iron‑deficiency anemia.
• Breast tenderness or galactorrhea (milk production) – may indicate prolactin excess.
• Changes in bowel or bladder habits (pressure from large fibroids).
• Fever, chills, or foul‑smelling vaginal discharge – could signal infection.

When to See a Doctor

While occasional variation is normal, the following situations merit prompt medical evaluation:

• Bleeding lasting more than 7 days or requiring a change of pad/tampon every hour.
• Passing clots larger than a quarter (≈ 1 cm) in diameter.
• Sudden onset of heavy bleeding after previously light periods.
• Bleeding that interferes with daily activities, work, or school.
• Symptoms of anemia (fatigue, dizziness, rapid heartbeat, shortness of breath).
• Bleeding after menopause (any vaginal bleeding > 12 months after the last period).
• Unexplained weight loss, pelvic pain, or a feeling of pressure/bulge in the abdomen.

Diagnosis

Evaluation begins with a thorough history and physical exam, followed by targeted investigations.

1. Medical History & Physical Exam

• Cycle length, flow characteristics, age at menarche, and menopause status.
• Medication, supplement, and contraceptive use.
• Family history of bleeding disorders, thyroid disease, or gynecologic cancers.
• Pelvic exam to assess uterine size, adnexal masses, and cervical pathology.

2. Laboratory Tests

• Complete blood count (CBC) – looks for anemia.
• Ferritin and iron studies – assess iron stores.
• Coagulation profile: PT/INR, aPTT, and specific tests for von Willebrand disease.
• Thyroid‑stimulating hormone (TSH) – screens for hypo/hyperthyroidism.
• Pregnancy test – always rule out early pregnancy.

3. Imaging & Specialized Exams

• Transvaginal ultrasound – first‑line for fibroids, polyps, adenomyosis.
• Sonohysterography (saline‑infused ultrasound) – better visualization of intracavitary lesions.
• Endometrial biopsy – indicated for women > 45 years with abnormal bleeding or any post‑menopausal bleeding.
• Magnetic Resonance Imaging (MRI) – helpful for complex fibroids or deep infiltrating adenomyosis.
• Hysteroscopy – direct visual inspection and possible removal of polyps or submucosal fibroids.

Treatment Options

Treatment is individualized based on cause, severity, reproductive plans, and patient preference.

Medical Management

• Tranexamic acid (TXA) – short‑term antifibrinolytic that reduces heavy bleeding (600 mg every 8 h during menses).
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – reduce menstrual blood loss by 20‑30 % (e.g., ibuprofen 400 mg q6‑8 h).
• Combined oral contraceptives (COCs) – stabilize hormonal fluctuations; can be cyclic or continuous.
• Progesterone‑only options – oral norethindrone, levonorgestrel IUS (Mirena) – especially effective for fibroids and adenomyosis.
• Gonadotropin‑releasing hormone (GnRH) agonists/antagonists – temporarily shrink fibroids; used short‑term due to menopausal‑like side effects.
• Iron supplementation – oral ferrous sulfate 325 mg daily or intravenous iron for severe deficiency.

Surgical & Procedural Options

• Endometrial ablation – destroys the uterine lining, suitable for women who have completed childbearing.
• Myomectomy – removal of fibroids while preserving the uterus.
• Uterine artery embolization (UAE) – interventional radiology technique to cut blood supply to fibroids.
• Hysterectomy – definitive treatment for refractory bleeding; considered after counseling about fertility loss.
• Polypectomy or D&C – removal of polyps or abnormal tissue via hysteroscopic instruments.

Lifestyle & Home Remedies

• Maintain a balanced diet rich in iron (red meat, leafy greens, legumes).
• Stay hydrated and engage in regular moderate exercise – can improve hormonal balance.
• Use heat therapy (warm packs) for dysmenorrhea associated with heavy flow.
• Track cycles with a smartphone app or calendar to detect patterns early.

Prevention Tips

While not all causes are preventable, the following strategies may reduce the risk of developing menstrual bleeding abnormalities:

• Regular gynecologic check‑ups, especially after age 35 or when using intrauterine devices.
• Screen for and manage thyroid disease early.
• Keep a healthy weight; obesity is linked to PCOS and estrogen excess.
• Limit use of medications that affect clotting unless medically necessary.
• Consider early treatment of fibroids with hormonal therapy if they are growing rapidly.
• Maintain adequate iron intake throughout the menstrual years to mitigate anemia.
• Promptly treat infections (e.g., pelvic inflammatory disease) which can scar the uterine lining.

Emergency Warning Signs

References

• Mayo Clinic. “Heavy menstrual bleeding.” https://www.mayoclinic.org
• Cleveland Clinic. “Abnormal uterine bleeding.” https://my.clevelandclinic.org
• American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 136: “Management of Abnormal Uterine Bleeding in Reproductive-Aged Women.” 2023.
• National Institutes of Health, Office of Dietary Supplements. “Iron.” https://ods.od.nih.gov
• World Health Organization. “WHO guidelines for the management of heavy menstrual bleeding.” 2022.

```